Skip to content

Clinical trials

Completed Hypercholesterolemia trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypercholesterolemia Status: Completed Country / region: Czechia Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20041
20051
20071
20081
20091
20114
20125
20137
20142
20152
20165
20173
20181
20191
20211
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed41

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen17
Sanofi6
Kastle Therapeutics, LLC2
NewAmsterdam Pharma2
Novartis Pharmaceuticals2
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2
Takeda2
The Medicines Company2
AstraZeneca1
Danone Global Research & Innovation Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypercholesterolemia41
Dyslipidemias7
Hyperlipoproteinemia Type II7
Hyperlipidemias6
Homozygous Familial Hypercholesterolemia4
Angina Pectoris1
Atherosclerosis1
Cardiovascular Diseases1
Coronary Artery Disease1
Coronary Disease1

Trials

Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.